SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-20-134958
Filing Date
2020-05-06
Accepted
2020-05-06 16:34:16
Documents
17
Period of Report
2020-05-05
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d926269d8k.htm   iXBRL 8-K 37613
2 EX-1.1 d926269dex11.htm EX-1.1 196371
3 EX-5.1 d926269dex51.htm EX-5.1 8648
4 EX-99.1 d926269dex991.htm EX-99.1 9758
5 EX-99.2 d926269dex992.htm EX-99.2 9778
9 GRAPHIC g926269snap0003.jpg GRAPHIC 2672
  Complete submission text file 0001193125-20-134958.txt   458691

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA kura-20200505.xsd EX-101.SCH 3081
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE kura-20200505_lab.xml EX-101.LAB 18138
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE kura-20200505_pre.xml EX-101.PRE 11415
13 EXTRACTED XBRL INSTANCE DOCUMENT d926269d8k_htm.xml XML 3359
Mailing Address 3033 SCIENCE PARK ROAD, SUITE 220 SAN DIEGO CA 92121
Business Address 3033 SCIENCE PARK ROAD, SUITE 220 SAN DIEGO CA 92121 (858) 500-8800
Kura Oncology, Inc. (Filer) CIK: 0001422143 (see all company filings)

IRS No.: 611547851 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37620 | Film No.: 20853130
SIC: 2834 Pharmaceutical Preparations